Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

The Hotz-Celsus surgery successfully fixed inward-turning eyelids in cattle.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

No treatment is clearly better for central serous chorioretinopathy, and more research is needed.

Tofacitinib may help treat hair loss in children with alopecia areata.

Ethylenthiourea is toxic to the liver and nervous system, especially with alcohol.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Dermoscopy is a useful tool for diagnosing and managing topical steroid dependent face.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ethionine significantly inhibits wool growth in sheep but not hair growth in mice or rats.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Latanoprost 0.1% may effectively treat hair loss.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib may help regrow hair in alopecia areata patients.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Red light therapy temporarily increased blood flow in the eye but didn't change other eye structures.